Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicine for treating neurasthenia

A technology for neurasthenia and drugs, applied in drug combination, nervous system diseases, pharmaceutical formulations, etc., can solve the problems of unsuitable long-term use, large toxic and side effects, strong dependence, etc., and achieve good medical application prospects, good effects, and safety. high sex effect

Inactive Publication Date: 2015-04-22
潘锋
View PDF4 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] The treatment of neurasthenia by Western medicine mainly relies on diazepam and other hypnotic sedatives, which have serious side effects and strong dependence, so it is not suitable to take them for a long time

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0031] A drug for treating neurasthenia is composed of the following raw materials in parts by weight: 10g of cypress kernels, 15g of vine vine, 12g of Cuiyun grass, 9g of magnolia officinalis, 10g of Ligustrum lucidum, 10g of Qiannianjian, 5g of American ginseng, and mulberry branches 15g, Pinellia 6g, Atractylodes macrocephala 3g, Artemisia argyi 5g, honeysuckle 25g.

[0032] The preparation method of present embodiment medicine is as follows:

[0033] (1) Classify the medicines, Cuiyuncao, Magnolia officinalis, Ligustrum lucidum, Artemisia argyi and Honeysuckle are the last medicines, and the rest are the first medicines;

[0034] (2) Weigh the drug according to the formula, and soak it in 2000mL cold water for 2 hours;

[0035] (3) Weigh the medicine according to the formula, add 3 times of water, boil it with strong fire until it boils, and then cook it with slow fire for 20 minutes;

[0036] (4) Add the soaked drug to the decoction liquid of the first drug, decoct for ...

Embodiment 2

[0040] A medicine for treating neurasthenia is composed of the following raw materials in parts by weight: 15g of cypress kernels, 10g of broad tendon rattan, 10g of Cuiyuncao, 8g of magnolia officinalis flowers, 7g of privet privet fruit, 18g of Qiannianjian, 8g of American ginseng, mulberry twigs 12g, Pinellia 8g, Atractylodes macrocephala 4g, Artemisia argyi 3g, honeysuckle 18g.

[0041] The preparation method of the medicine of this embodiment is the same as that of Example 1.

Embodiment 3

[0043] A drug for treating neurasthenia is composed of the following raw materials in parts by weight: 20g of cypress kernels, 5g of broad tendon rattan, 8g of Cuiyuncao, 6g of magnolia officinalis, 5g of Ligustrum lucidum, 25g of Qiannianjian, 11g of American ginseng, mulberry branches 8g, Pinellia 10g, Atractylodes macrocephala 5g, Artemisia argyi 1g, honeysuckle 12g.

[0044] The preparation method of the medicine of this embodiment is the same as that of Example 1.

[0045] Clinical Observation

[0046] 1. Clinical data

[0047] The inventor carried out clinical observation and treatment to 250 patients, all of whom were neurasthenia patients diagnosed by clinicians, including 100 males and 150 females, aged 15-72 years, with an average age of 38.5 years.

[0048] 2. Drug selection

[0049] Decoction in water, one side is one dose, one dose a day, twice a day, 200ml in the morning and evening half an hour after meals. 7 days is a course of treatment, and the treatmen...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses medicine for treating neurasthenia. The medicine for treating neurasthenia consists of, by weight, 10-20 parts of platycladi seeds, 5-15 parts of tinospora sinensis, 8-12 parts of uncinata spikemoss herb, 6-9 parts of official magnolia flower, 5-10 parts of glossy privet fruits, 10-25 parts of obscured homalomena rhizome, 5-11 parts of American ginseng, 8-15 parts of ramulus mori, 6-10 parts of processed pinellia tuber, 3-5 parts of white atractylodes rhizome, 1-5 parts of folium artemisiae argyi and 12-25 parts of honeysuckle. The medicine uses pure traditional Chinese medicine as a raw material, multiple kinds of traditional Chinese medicine are organically combined, complement mutually, play synergistic effect, has good effects of clearing away the heart-fire, strengthening brain, soothing nerves, nourishing yin and generating body fluid, has good treatment effect on the neurasthenia, is free of toxic and side effects, high in safety and good in long-term usage effect, is safe and effective neurasthenia treating medicine and has good medical application prospect.

Description

technical field [0001] The invention relates to the field of application of traditional Chinese medicines, in particular to a medicine for treating neurasthenia. Background technique [0002] Most scholars believe that mental factors are the main cause of neurasthenia. Any factors that can cause continuous tension and long-term inner conflicts will make the nervous activity process in a strong and persistent state of tension, exceeding the tolerance limit of nervous system tension. Neurasthenia can occur. The activity of the human central nervous system plays a leading role in various activities of the body. The nerve cells of the cerebral cortex have a fairly high tolerance, and generally do not easily cause neurasthenia or failure. After intense mental work, although fatigue occurs, it can be recovered after a short rest or sleep. However, once the nervous activity in a state of intense tension exceeds the tolerance limit, neurasthenia may occur. Neurasthenia is charact...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/8888A61P25/00A61P25/20
CPCA61K36/14A61K9/0095A61K36/11A61K36/258A61K36/282A61K36/284A61K36/355A61K36/575A61K36/59A61K36/605A61K36/638A61K36/888A61K36/8888A61K2300/00
Inventor 潘锋李娜
Owner 潘锋
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com